Cambridge, MA, United States of America

Etzer Darout

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Pfizer Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Etzer Darout. Retrieved from https://idiyas.com/inventor/etzer-darout

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Etzer Darout

Introduction

Etzer Darout is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in reducing plasma lipid levels.

Latest Patents

Etzer Darout holds a patent for substituted amide compounds. This invention is directed at pharmaceutical compositions containing such compounds and their use in reducing plasma lipid levels, including LDL-cholesterol and triglycerides. The implications of this invention are profound, as it addresses diseases exacerbated by high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in mammals, including humans. He has 1 patent to his name.

Career Highlights

Etzer Darout is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions that can improve health outcomes for patients.

Collaborations

Throughout his career, Etzer has collaborated with notable colleagues, including Paula M Loria and Julie Jia Li Hawkins. These collaborations have further enriched his research and development efforts.

Conclusion

Etzer Darout's contributions to pharmaceutical innovations highlight the importance of research in addressing critical health issues. His work continues to pave the way for advancements in treating cardiovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…